MarketLens

Has Xeris Biopharma Reached an Inflection Point

3 months ago

SHARE THIS ON:

Exclusive Content for Pro Members

Pro members only. Upgrade to access this article, premium analysis, and stock recommendations.

SHARE THIS ON:

Has China's EV Market Reached an Inflection Point for BYD

6 months ago

Has Genasys (GNSS) Finally Reached an Inflection Point

4 months ago

Has Amprius Technologies Reached a Critical Inflection Point

6 months ago

General Mills' Q4 Beat: An Inflection Point in a Price-Sensitive Market

2 months ago

InfuSystems: More Upside Ahead

InfuSystems raised FY25 adjusted EBITDA 24% after shifting to a profit-focused strategy, with Wound Care revenue up 154% on partnerships and reimbursement. Net debt stands at 0.61x EBITDA with $55.2M ...

Stock News•3 weeks ago

Xeris Biopharma: A Commercial Stage Pharma That May Be A Slow-Burn Buy Opportunity

Xeris Biopharma reported record 2024 revenues of $203M, up 24%, and guided 2025 revenue to $255M–$275M, implying ~30% growth at midpoint. XP-8121, a once-weekly levothyroxine, targets a $1B+ U.S. mark...

XERS

Stock News•2 months ago

DexCom: The Growth Thesis Still Needs To Be Proven

DexCom faces a pivotal transition as GLP-1 adoption threatens its core insulin-treated diabetes market. At 28x earnings, valuation offers limited upside until CGM adoption in Type 2 non-insulin patien...

DXCM

Breaking News

Clinical Trials (Phase I, II, III)

Creator Economy

Crude Oil (WTI/Brent)

Top Headlines

View More →

Stock News•2 hours ago

Cybersecurity Is the Next Big Market for Artificial Intelligence (AI), According to Jensen Huang. This Super Stock-Split Stock Is the One to Own.

Stock News•2 hours ago

Viral AI Dommer Tweet: Engineered Panic?

Stock News•3 hours ago

Jeff Bezos Built Amazon Into a $1.8 Trillion Company. Here's How Andy Jassy Is Making It Worth Even More.

Stock News•4 hours ago

Apple Bought Back More Than $880 Billion of Its Own Stock During Tim Cook's 15 Years as CEO. Here's How That Reshaped Shareholder Returns.

Stock News•6 hours ago

Has Xeris Biopharma Reached an Inflection Point

Exclusive Content for Pro Members

Related Articles

Has China's EV Market Reached an Inflection Point for BYD

Has Genasys (GNSS) Finally Reached an Inflection Point

Has Amprius Technologies Reached a Critical Inflection Point

General Mills' Q4 Beat: An Inflection Point in a Price-Sensitive Market

Category

You may also like

InfuSystems: More Upside Ahead

Xeris Biopharma: A Commercial Stage Pharma That May Be A Slow-Burn Buy Opportunity

DexCom: The Growth Thesis Still Needs To Be Proven

Breaking News

Featured Articles

DoorDash (DASH): Founder Selling Signals Liquidity, Not Lack of Confidence Amid Robust Growth

Sea Limited's Growth Momentum Outweighs COO's Programmed De-risking

Arista Networks' AI Momentum Encounters Founder's Planned Profit-Taking

Top Headlines

Cybersecurity Is the Next Big Market for Artificial Intelligence (AI), According to Jensen Huang. This Super Stock-Split Stock Is the One to Own.

Viral AI Dommer Tweet: Engineered Panic?

Jeff Bezos Built Amazon Into a $1.8 Trillion Company. Here's How Andy Jassy Is Making It Worth Even More.

Apple Bought Back More Than $880 Billion of Its Own Stock During Tim Cook's 15 Years as CEO. Here's How That Reshaped Shareholder Returns.

Warren Buffett Made Apple Berkshire Hathaway's Single Largest Stock Position: $10,000 Invested 10 Years Ago Would Be Worth Roughly $122,400 Today